Anavex Life Sciences Corp (AVXL)

[bas2020]

Baseless nonsense...

Any thoughts as to why Anavex is so obsessed with using responder/OR as endpoint measures

It's clearly evident that ORs were in addition to the trial results that met all endpoints, where mean scores were provided.
Because no other AD P3 trial has ever produced Super Responders, Anavex included the ORs to highlight them.
Those n's are >3x and >4x, over placebo, for both Cog and ADL, respectively. Expect the treated n to be 60-80... much more than a "few".
Do you need to be reminded... on average, there was a 45% reduction in Cognitive decline vs. placebo, as the results provided.